Retrospective Analysis of Survival Outcomes Among Patients with Amyotrophic Lateral Sclerosis Who Received an Investigational Treatment, NP001, in Phase 2 Clinical Trials
Research Grant
Administered By
Neurology
Awarded By
Neuvivo, Inc.
Start Date
July 27, 2023
End Date
April 22, 2024
Administered By
Neurology
Awarded By
Neuvivo, Inc.
Start Date
July 27, 2023
End Date
April 22, 2024